article thumbnail

Clinical Trial Explores CBD’s Influence on Cannabis Safety

Veriheal

A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. .

article thumbnail

First Ever Clinical Trial for Cannabis Migraine Treatment is Underway

Veriheal

However, there has not been a clinical trial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinical trial for cannabis as a migraine treatment is underway.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care.

article thumbnail

Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis

NORML

“This study demonstrates that treatment with THC-rich cannabis in patients with mild to moderate UC is associated with clinical improvement.". The post Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis appeared first on NORML.

article thumbnail

Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients

NORML

“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".

article thumbnail

Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia

NORML

The post Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia appeared first on NORML. "We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients.".

article thumbnail

Cancer patients medicate with cannabis with or without clinical trials

Cannabis Life Network

Clinical evidence, however, has yet prove that cannabinoids, terpenes, or cannabis treat cancer. With or without clinical trials, though, cancer patients who medicate with cannabis remain optimistic in Canada and The Netherlands. (1,

article thumbnail

South Africa – New cannabis clinical trial launched

Cannabis Law Report

Cannabis Law TV

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

article thumbnail

MindMed’s Mescaline Study Approved For Clinical Trial

Cannabis Law Report

MindMed (Nasdaq: MNMD) announced today that its clinical trial plans to evaluate the acute effects of serotonergic hallucinogen mescaline have… Read More.

article thumbnail

Chanelle McCoy Granted Approval For Significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial

Cannabis Law Report

PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.

article thumbnail

Numinus Announces Clinical Trial Of Psilocybin-Assisted Psychotherapy

Cannabis Life Network

announced early this morning that it will undertake a clinical trial of psilocybin-assisted psychotherapy. About the Research & Clinical Trial Numinus Wellness […]. Vancouver based Numinus Wellness Inc.

article thumbnail

House Passes Bipartisan Bill Facilitating Clinical Cannabis Research, Allowing Scientists to Access State-Approved Marijuana Products

NORML

The post House Passes Bipartisan Bill Facilitating Clinical Cannabis Research, Allowing Scientists to Access State-Approved Marijuana Products appeared first on NORML. LEGISLATION Research SCIENCE clinical trials DEA House vote research University of Mississippi

article thumbnail

CBG is safe, gets green light for clinical trials and therapy

Cannabis Life Network

Even as a common name, CBG had yet to undergo the same tests and clinical trials as CBD to ensure high doses are safe. The post CBG is safe, gets green light for clinical trials and therapy appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks.

article thumbnail

Psychedelic Clinical Trials & Who’s Behind Them

Cannabis Law Report

The post Psychedelic Clinical Trials & Who’s Behind Them first appeared on Cannabis Law Report. CFN report… The psychedelics industry has experienced unprecedented growth over the past few years, driven by a combination of emerging… Read More.

article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. POTOMAC, Md.–(BUSINESS

article thumbnail

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Cannabis Law Report

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The Principal Investigator for the trial will be Kevin Boehnke, Ph.D.,

article thumbnail

MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine

Cannabis Law Report

Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc.

article thumbnail

Teon Therapeutics Announces Clinical Trial Collaboration With Merck to Evaluate TT-816, a Novel Oral Immune Response Modifier, in Combination with KEYTRUDA® (pembrolizumab)

Cannabis Law Report

article thumbnail

NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

Cannabis Law Report

The post NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials first appeared on Cannabis Law Report. We hope he does a better job than some of the playlists we’ve seen recently ! NeonMind Biosciences Inc. … Read More.

article thumbnail

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Cannabis Law Report

Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial. VANCOUVER, BC, May 11, 2021 /CNW/… Read More. Cannabis Finance News

article thumbnail

ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)

Cannabis Law Report

NEW YORK & GREENWOOD VILLAGE, Colo.–(BUSINESS –(BUSINESS WIRE)–ANANDA Scientific Inc.,

article thumbnail

FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

Cannabis Law Report

Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19.

article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin.

article thumbnail

UK: Imperial College Of London To Study DMT In First-Ever Clinical Trial

Cannabis Law Report

Clinical trials on the hallucinogenic drug DMT for the treatment of depression are expected to start in January. The post UK: Imperial College Of London To Study DMT In First-Ever Clinical Trial first appeared on Cannabis Law Report. Yahoo Finance Reports.

article thumbnail

Press Release: Creso Pharma’s psychedelics company cleared to start clinical trials

Cannabis Law Report

has secured Clinical Trial Authorisation (CTA) with Health Canada. The CTA positions Halucenex as one of the few companies in Canada with clearance to begin a clinical trial utilising psychedelic substances.

article thumbnail

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally.

article thumbnail

Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial

Cannabis Law Report

The clinical trial involving the use of Filament’s psilocybin received approval from Health Canada and was conducted as part of ATMA Journey Centre’s psychedelic-assisted therapist training program. Mugglehead report.

article thumbnail

ZYUS Announces Database Lock for its Phase 1 First-in-Human Clinical Trial

Cannabis Law Report

article thumbnail

South African Research Team Says Cannabis is ‘Very Promising’ as an Opioid Replacement

Veriheal

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

article thumbnail

Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.

Cannabis Law Report

As a member of Ehave’s Medical Advisory Board, Dr. Desai’s main responsibilities will be to assist and advise the Company on human trials for its cognitive and psychedelic opportunities, as well as assist and advise the Company on mental health analytical platforms.

article thumbnail

Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain

NORML

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine. Polish investigators conducted a randomized, double-blind placebo-controlled trial assessing the efficacy of twice-daily transdermal CBD administration on 60 patients with TMD over a period of 14 days.

article thumbnail

Japanese Officials Approve Epidiolex For Clinical Trials

Cannabis Law Report

The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Ministry of Health, Labor and Welfare officials recently announced the trials during a meeting of the Okinawa-Northern Task Force, a research and development agency. Japanese officials approve Epidiolex for clinical trials.

article thumbnail

Orcosa Comments on Positive Results of NYU Langone’s Phase 1/2 Clinical Trial Utilizing ORAVEXX™

Cannabis Law Report

The trial, which was conducted jointly at NYU Langone and Baptist Health/Jacksonville Orthopaedic Institute and led by Principal Investigator Dr. Michael J. EWING, N.J.–(BUSINESS –(BUSINESS WIRE)– Orcosa Inc.

article thumbnail

Teon Therapeutics Announces Clinical Trial Collaboration With Merck to Evaluate TT-816, a Novel Oral Immune Response Modifier, in Combination with KEYTRUDA® (pembrolizumab)

Medical Marijuana Program Connection

SAN FRANCISCO–(BUSINESS WIRE)–Teon Therapeutics (Teon), a clinical-stage biopharmaceutical company targeting metabolic signaling pathways and pioneering the development of G-Protein Coupled.

article thumbnail

Incannex (ASX: IHL) partners with Procaps to develop cannabis medicine for clinical trial on sleep apnea

Cannabis Law Report

The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinical trials. If these trials are successful and IHL-42X is approved for the market, Procaps will also make IHL-42X for patients.